Company Filing History:
Years Active: 2001
Title: Edward I Holupka: Innovator in Prostate Cancer Treatment
Introduction
Edward I Holupka is a notable inventor based in Medway, MA (US). He has made significant contributions to the field of medical technology, particularly in the treatment of prostate cancer. His innovative approach combines ultrasound imaging with radiation therapy to enhance treatment accuracy.
Latest Patents
Holupka holds a patent for "Ultrasound localization and image fusion for the treatment of prostate cancer." This invention presents a method and apparatus designed to localize and treat a patient's prostate through radiation therapy. The system incorporates an ultrasound probe that generates an ultrasound image of the prostate, utilizing at least two fiducial end points as landmarks. Additionally, it includes a CT apparatus that produces X-ray simulator images of the anatomical region near the prostate. A computer executes software to transform the ultrasound image into the simulator image, enabling precise localization of the prostate in relation to nearby anatomical features. This innovation facilitates accurate radiation therapy for prostate cancer patients.
Career Highlights
Holupka is affiliated with the Associates of the Joint Center for Radiation Therapy, Inc., where he applies his expertise in medical imaging and radiation therapy. His work has been instrumental in advancing treatment methodologies for prostate cancer, showcasing his commitment to improving patient outcomes.
Collaborations
Some of his notable coworkers include Irving D Kaplan and Everette C Burdette. Their collaborative efforts contribute to the ongoing development of innovative solutions in radiation therapy.
Conclusion
Edward I Holupka's contributions to the field of prostate cancer treatment through his patented technology exemplify the impact of innovation in healthcare. His work continues to influence the way radiation therapy is administered, ultimately benefiting patients in need of effective treatment options.